Results of the Scheme and Issue of Scheme Shares

JPMorgan Global Growth & Income PLC
26 March 2024
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA, IN ANY MEMBER STATE OF THE EEA OR IN ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.

This announcement is not an offer to sell, or a solicitation of an offer to acquire, securities in the United States or in any other jurisdiction in which the same would be unlawful. Neither this announcement nor any part of it shall form the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever.

 

Legal Entity Identifier: 5493007C3I0O5PJKR078

 

26 March 2024

 

JPMorgan Global Growth & Income plc

Rollover of assets from JPMorgan Multi-Asset Growth & Income plc

Results of the Scheme and Issue of Scheme Shares

Results of the Scheme and Issue of Scheme Shares

The Board of JPMorgan Global Growth & Income plc (the "Company" or "JGGI") is pleased to announce that the Company will acquire substantially all of the net assets from JPMorgan Multi-Asset Growth & Income plc ("MATE") in exchange for the issue of 13,546,292 new shares in the capital of JGGI ("Scheme Shares") in connection with the voluntary winding up of MATE pursuant to a scheme of reconstruction under section 110 of the Insolvency Act 1986 (the "Scheme") following the passing today of the resolution proposed at the Second General Meeting of MATE.

 

JGGI ordinary shares

The number of Scheme Shares to be issued to Eligible MATE Shareholders and to the Liquidators of MATE for sale in the market for the benefit of Excluded MATE Shareholders was calculated based on a FAV per JGGI share of 552.086482 pence and a FAV per MATE share of 104.063823 pence, producing a conversion ratio of approximately 0.188492 JGGI shares per MATE share rolling over, each calculated in accordance with the Scheme.

As set out in the shareholder circular published by the Company on 23 February 2024 (the "Circular"), fractions of Scheme Shares arising as a result of the conversion ratio will not be issued under the Scheme and entitlements to such Scheme Shares will be rounded down to the nearest whole number.

 

Admission

Applications have been made by the Company to the FCA for the Scheme Shares to be admitted to the premium listing category of the Official List and to the London Stock Exchange for the Scheme Shares to be admitted to trading on the premium segment of the Main Market (together, "Admission"). It is expected that Admission will take place at 8.00am on 27 March 2024.

Following the issue of the Scheme Shares noted above, the Company's share capital will comprise 464,057,308 ordinary shares (excluding treasury shares), with each ordinary share entitled to one voting right per ordinary Share such that, following Admission, the total voting rights of the Company will be 464,057,308. The Company does not hold any shares held in treasury.

The figure of 464,057,308 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in voting rights, or a change to their interest in the Company, under the Disclosure, Guidance and Transparency Rules.

Capitalised terms used but not defined in this announcement will have the same meaning as set out in the Circular.

 

For further information:

 

JPMorgan Global Growth & Income plc

Tristan Hillgarth

 

Contact via Company Secretary

JPMorgan Funds Limited

Simon Crinage

Fin Bodman

 

+44 (0) 20 7742 4000

JPMorgan Funds Limited (Company Secretary)

Divya Amin

 

+44 (0) 20 7742 4000

Winterflood Securities Limited

Neil Langford

Haris Khawaja

 

+44 (0) 20 3100 0000









 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings